HLA tapasin independence broader peptide repertoire and HIV control
Human leukocyte antigen (HLA) class I allotypes vary in their ability to present peptides in the absence of tapasin, an essential component of the peptide loading complex.We quantified tapasin dependence of all allotypes that are common in European and African Americans (n = 97), which revealed a br...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 117; no. 45; pp. 28232 - 28238 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
10.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Human leukocyte antigen (HLA) class I allotypes vary in their ability to present peptides in the absence of tapasin, an essential component of the peptide loading complex.We quantified tapasin dependence of all allotypes that are common in European and African Americans (n = 97), which revealed a broad continuum of values. Ex vivo examination of cytotoxic T cell responses to the entire HIV-1 proteome from infected subjects indicates that tapasin-dependent allotypes present a more limited set of distinct peptides than do tapasin-independent allotypes, data supported by computational predictions. This suggests that variation in tapasin dependence may impact the strength of the immune responses by altering peptide repertoire size. In support of this model, we observed that individuals carrying HLA class I genotypes characterized by greater tapasin independence progress more slowly to AIDS and maintain lower viral loads, presumably due to increased breadth of peptide presentation. Thus, tapasin dependence level, like HLA zygosity, may serve as a means to restrict or expand breadth of the HLA-I peptide repertoire across humans, ultimately influencing immune responses to pathogens and vaccines. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Edited by Rafi Ahmed, Emory University, Atlanta, GA, and approved September 8, 2020 (received for review June 29, 2020) Author contributions: A.A.B., W.G.-B., and M.C. designed research; A.A.B., M.A., and Y.Y. performed experiments; A.G., P.G., A.S., and J.C. contributed to the peptide repertoire data collection and analyses; M.V., V.N., X.G., C.O., M.R., P.C., and T.E. analyzed data; A.A.B. and M.C. wrote the paper; and S.W., J.H.B., P.D., J.M., N.L.M., G.D.K., S.P.B., D.H., J.J.G., S.G.D., J.F., and B.W. designed HIV cohorts and collected data. |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.2013554117 |